EGFR-mutated non-small cell lung cancer (NSCLC) accounts for approximately 15% of lung adenocarcinomas in Western populations and up to 50% in Asian cohorts [ 1 ]. Tyrosine kinase inhibitors (TKIs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback